Zhang Xi,Gao Lei.Research progress of haploidentical hematopoietic transplantation without T-cell depletion[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(12):1331-1339.
Zhang Xi,Gao Lei.Research progress of haploidentical hematopoietic transplantation without T-cell depletion[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(12):1331-1339.DOI:
Research progress of haploidentical hematopoietic transplantation without T-cell depletion
Human leukocyte antigen (HLA)-haploidentical hematopoietic stem cell transplantation (HLA-haplo HSCT) without T-cell depletion has tremendously progressed over the past 20 years. Advances in graft manipulation
conditioning regimens
and pharmacological graft-versus-host disease (GVHD) prophylaxis have reduced the risk of fatal graft failure and severe GVHD. Donor-specific anti-HLA antibodies (DSA) negative status and killer immunoglobulin-like receptor (KIR) mismatch play potential roles in reducing the risk of graft failure and GVHD following HLA-haplo HSCT. New strategies to improve HLA-haplo HSCT outcomes include donor lymphocyte
selected T-cell subset and NK cell infusion
mesenchymal stem cell (MSC) co-transplantation and interleukin-2 application. Future challenges remain in improving post-transplant immune reconstitution and finding the best approach to reduce the incidence and severity of GVHD while simultaneously preserving the graft-versus leukemia effect to prevent the recurrence of underlying malignancy.
Ibrutinib for treatment of autoimmune cytopenia after hematopoietic stem cell transplantation: report of 2 cases and literature review
Second hematopoietic stem cell transplantation with a new haploid-mismatched donor in relapsed patients after first transplantation: prognostic analysis of 11 cases
Clinical significance of screening donor related genes for allogeneic hematopoietic stem cell transplantation in treatment of inherited bone marrow failure syndrome in adults and analysis on clinical efficacy
Second allogeneic hematopoietic stem cell transplantation in treatment of relapsed acute myeloid leukemia: clinical report of 5 cases
Induction and features of relapsing experimental autoimmune uveoretinitis in mice